The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2011

Filed:

Sep. 16, 2003
Applicants:

Sylvie Roux, Paris, FR;

Philippe Brulet, Paris, FR;

Cécile Saint Cloment, Paris, FR;

Julien Barbier, Paris, FR;

Jordi Molgo, Paris, FR;

Inventors:

Sylvie Roux, Paris, FR;

Philippe Brulet, Paris, FR;

Cécile Saint Cloment, Paris, FR;

Julien Barbier, Paris, FR;

Jordi Molgo, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/567 (2006.01); C07K 1/00 (2006.01); C07K 14/00 (2006.01); A61K 38/24 (2006.01);
U.S. Cl.
CPC ...
Abstract

A hybrid protein (GFP-TTC) comprising the non-toxic proteolytic C fragment of tetanus toxin fused to green fluorescent protein was used to analyze the functional synaptic organization of neural networks. When injected intramuscularly in vivo, the GFP-TTC hybrid protein binds to tetanus neurotoxin receptors and clusters very rapidly to the active neuromuscular junction. Membrane traffic by GFP-TTC at the pre-synaptic level of the neuromuscular junction is strongly and rapidly influenced by exogenously co-injecting neurotrophic factors, such as BDNF, NT-4, and GDNF, but not by NGF, NT-3, and CNTF. The membrane traffic, directly detected using GFP-TTC in vivo, permits methods of analyzing synaptic functioning as well as methods of modulating neuronal transport using neurotrophic factors and agonists or antagonists thereof.


Find Patent Forward Citations

Loading…